Posterior Reversible Encephalopathy Syndrome in the Context of Phentermine Use Resulting in Intracranial Hemorrhage

被引:3
作者
Wong, Victoria S. S. [1 ]
Singh, Harpreet [1 ]
Verro, Piero [1 ]
机构
[1] Univ Calif Davis, Med Ctr, Dept Neurol, Sacramento, CA 95817 USA
关键词
posterior reversible encephalopathy syndrome; PRES; phentermine; intracranial hemorrhage; HYPERTENSIVE ENCEPHALOPATHY; LEUKOENCEPHALOPATHY SYNDROME; NEUROTOXICITY; FENFLURAMINE; FEATURES; OBESITY; STROKE;
D O I
10.1097/NRL.0b013e31820a9ddc
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Posterior reversible encephalopathy syndrome (PRES) is a brain disorder characterized by clinical symptoms of headache, visual changes, altered mentation, and seizures. On neuroimaging, focal regions of symmetrical hemispheric edema are most commonly seen in the occipital lobes. It has been suggested that associated intracranial hemorrhage is present in approximately 5% to 17% of cases. We report a case of PRES with large bilateral parieto-occipital hemorrhages in the context of phentermine use. To our knowledge, this is the first reported case of phentermine use associated with PRES. Case Report: A 35-year-old woman taking phentermine for weight loss presented with altered mental status and 2 witnessed generalized seizures. She was found to have large bilateral parieto-occipital hemorrhages. The radiographic imaging was consistent with PRES with hemorrhagic conversion. After treatment with anti-epileptic medication, normalization of blood pressure, and discontinuation of phentermine, the patient improved clinically. Five months after the event, the patient had a repeat brain magnetic resonance imaging that showed resolution of the diffuse edema and hemorrhage. Conclusions: This case of PRES with hemorrhagic conversation is distinctive in the bilateral and extensive nature of the hemorrhage, and, to our knowledge, is the first reported case of phentermine use likely resulting in PRES. Physicians should be aware of the cerebrovascular risks associated with phentermine use.
引用
收藏
页码:111 / 113
页数:3
相关论文
共 17 条
  • [1] Posterior reversible encephalopathy syndrome, part 1: Fundamental imaging and clinical features
    Bartynski, W. S.
    [J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 2008, 29 (06) : 1036 - 1042
  • [2] Posterior reversible encephalopathy syndrome, part 2: Controversies surrounding pathophysiology of vasogenic edema
    Bartynski, W. S.
    [J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 2008, 29 (06) : 1043 - 1049
  • [3] Watershed imaging features and clinical vascular injury in cyclosporin A neurotoxicity
    Bartynski, WS
    Grabb, BC
    Zeigler, Z
    Lin, L
    Andrews, DF
    [J]. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1997, 21 (06) : 872 - 880
  • [4] CAPLAN LR, 1994, INTRACEREBRAL HEMORR, P210
  • [5] Chou Mei-Chun, 2004, Kaohsiung Journal of Medical Sciences, V20, P381
  • [6] Use of dexfenfluramine, fenfluramine and phentermine and the risk of stroke
    Derby, LE
    Myers, MW
    Jick, H
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 47 (05) : 565 - 569
  • [7] POSSIBLE ASSOCIATION OF ISCHEMIC STROKE WITH PHENTERMINE
    KOKKINOS, J
    LEVINE, SR
    [J]. STROKE, 1993, 24 (02) : 310 - 313
  • [8] LAI CH, 2003, CHANGHUA J MED, V8, P252
  • [9] Clinical spectrum of reversible posterior leukoencephalopathy syndrome
    Lee, Vivien H.
    Wijdicks, Eelco F. M.
    Manno, Edward M.
    Rabinstein, Alejandro A.
    [J]. ARCHIVES OF NEUROLOGY, 2008, 65 (02) : 205 - 210
  • [10] Meta-analysis: Pharmacologic treatment of obesity
    Li, ZP
    Maglione, M
    Tu, WL
    Mojica, W
    Arterburn, D
    Shugarman, LR
    Hilton, L
    Suttorp, M
    Solomon, V
    Shekelle, PG
    Morton, SC
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 142 (07) : 532 - 546